Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2023 Jun;54(2):662-671.
doi: 10.1007/s12029-022-00850-y. Epub 2022 Aug 1.

The Prognostic Role of Baseline Eosinophils in HPV-Related Cancers: a Multi-institutional Analysis of Anal SCC and OPC Patients Treated with Radical CT-RT

Margherita Rimini  1 , Pierfrancesco Franco  2 , Federica Bertolini  3 , De Bari Berardino  4   5 , Zampino Maria Giulia  6 , Vegge Stefano  7 , Kalliopi Andrikou  8 , Francesca Arcadipane  9 , Martina Napolitano  3 , Lavajo Vieira Buno  4 , Gerardi Marianna Alessandra  6 , Francesco Olivero  9 , Filippo Ferreri  9 , Umberto Ricardi  9 , Stefano Cascinu  1 , Andrea Casadei-Gardini  1
Affiliations
Multicenter Study

The Prognostic Role of Baseline Eosinophils in HPV-Related Cancers: a Multi-institutional Analysis of Anal SCC and OPC Patients Treated with Radical CT-RT

Margherita Rimini et al. J Gastrointest Cancer. 2023 Jun.

Abstract

Background and aim: Anal squamous cell carcinoma (SCC) and oropharyngeal cancer (OPC) are rare tumors associated with HPV infection. Bioumoral predictors of response to chemoradiation (CT-RT) are lacking in these settings. With the aim to find new biomarkers, we investigated the role of eosinophils in both HPV-positive anal SCC and HPV-related oropharyngeal cancer (OPC).

Methods: We retrieved clinical and laboratory data of patients with HPV-positive anal SCC treated with CT-RT in 5 institutions, and patients with locally advanced OPC SCC treated with CT-RT in 2 institutions. We examined the association between baseline eosinophil count (the best cutoff has been evaluated by ROC curve analysis: 100 × 10^9/L) and disease-free survival (DFS). Unadjusted and adjusted hazard ratios by baseline characteristics were calculated using the Cox proportional hazards model.

Results: Three hundred four patients with HPV-positive anal SCCs and 168 patients with OPCs (122 HPV-positive, 46 HPV-negative diseases) were analyzed. In anal SCC, low eosinophil count (< 100 × 10^9/L) correlates to a better DFS (HR = 0.59; p = 0.0392); likewise, in HPV-positive OPC, low eosinophil count correlates to a better DFS (HR = 0.50; p = 0.0428). In HPV-negative OPC, low eosinophil count confers worse DFS compared to high eosinophil count (HR = 3.53; p = 0.0098). After adjustment for age and sex, eosinophils were confirmed to be independent prognostic factors for DFS (HR = 4.55; p = 0.0139).

Conclusion: Eosinophil count could be used as a prognostic factor in anal HPV-positive SCC. The worse prognosis showed in HPV-positive patients with high eosinophil count is likely to derive from an unfavorable interaction between the HPV-induced immunomodulation and eosinophils, which may hamper the curative effect of RT.

Keywords: Chemoradiotherapy; Eosinophils; HPV; Oropharyngeal cancer; Prognostic factor; Squamous cell anal cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Kaplan–Meier curves for DFS in the anal cancer cohort (A), HPV-positive head and neck cancer cohort (B), HPV-negative head and neck cancer cohort (C)
Fig. 2
Fig. 2
Kaplan–Meier curves for DFS according to the HPV status (HPV-positive vs HPV-negative in OPC cohort of patients)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin. 2008;258:71–96. doi: 10.3322/CA.2007.0010. - DOI - PubMed
    1. Daling JR, Madeleine MM, Johnson LG, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer. 2004;101:270–280. doi: 10.1002/cncr.20365. - DOI - PubMed
    1. Frisch M, Glimelius B, van Den Brule AJ, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med. 1997;337:1350–1358. doi: 10.1056/NEJM199711063371904. - DOI - PubMed
    1. UKCCCR Anal cancer Trial Working Party UK Co-ordination Committee on Cancer Research: Epidermoid anal cancer: results from the UKCCCR randomized trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet. 1996;348:1049–1054. doi: 10.1016/S0140-6736(96)03409-5. - DOI - PubMed
    1. Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer radiotherapy and gastrointestinal cooperative group. J Clin Oncol. 1997;15:2040–2049. doi: 10.1200/JCO.1997.15.5.2040. - DOI - PubMed

Publication types

MeSH terms